Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRS | ALDX | PYXS | ||
| Company | Aclaris Therapts | Aldeyra Therapeu | Pyxis Oncology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.25 | 4.81 | 2.17 | ||
| High | 4.55 | 5.01 | 2.39 | ||
| Low | 4.07 | 4.66 | 1.90 | ||
| Last | 4.32 | 4.81 | 2.10 | ||
| Change | +0.36 | +0.05 | -1.72 | ||
| % Change | +9.09% | +1.05% | -45.03% | ||
| Volume | 2,965,700 | 392,900 | 15,188,100 | ||
| 20-Day Average Volume | 5,999,760 | 556,520 | 1,597,770 | ||
| Previous Close | 3.96 | 4.76 | 3.82 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.52 | 5.07 | 3.94 | ||
| 20-Day Raw Stochastic | 78.23% | 43.64% | 5.73% | ||
| 20-Day Relative Strength | 74.84% | 45.17% | 30.02% | ||
| Weighted Alpha | +139.41 | +26.83 | +5.21 | ||
| Today's Opinion | 100% Buy | 24% Buy | 48% Sell | ||
| Previous Opinion | 100% Buy | 24% Buy | 24% Buy | ||
| Last Month's Opinion | 8% Buy | 64% Buy | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +98.17% since 11/14/24 | +12.65% since 11/14/24 | -50.93% since 11/14/24 | ||
| Low | 2.03 on 11/15/24 | 4.09 on 11/15/24 | 1.90 on 11/21/24 | ||
| High | 5.17 on 11/19/24 | 5.12 on 11/18/24 | 4.40 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +257.02% since 10/21/24 | -13.02% since 10/21/24 | -42.93% since 10/21/24 | ||
| Low | 1.21 on 10/22/24 | 4.09 on 11/15/24 | 1.90 on 11/21/24 | ||
| High | 5.17 on 11/19/24 | 6.17 on 10/22/24 | 5.39 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +240.16% since 08/21/24 | -10.26% since 08/21/24 | -42.15% since 08/21/24 | ||
| Low | 1.12 on 10/07/24 | 4.09 on 11/15/24 | 1.90 on 11/21/24 | ||
| High | 5.17 on 11/19/24 | 6.55 on 09/05/24 | 5.39 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +266.10% since 05/21/24 | +22.08% since 05/21/24 | -47.50% since 05/21/24 | ||
| Low | 0.95 on 05/29/24 | 3.10 on 07/05/24 | 1.90 on 11/21/24 | ||
| High | 5.17 on 11/19/24 | 6.55 on 09/05/24 | 5.39 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,867 | 283,458 | 227,160 | ||
| Shares Outstanding, K | 71,431 | 59,550 | 59,466 | ||
| Annual Sales | 31,250,000 | 0 | 0 | ||
| Annual Net Income | -88,480,000 | -37,540,000 | -73,790,000 | ||
| Last Quarter Sales | 4,350,000 | 0 | 0 | ||
| Last Quarter Net Income | -7,590,000 | -15,110,000 | -17,300,000 | ||
| 60-Month Beta | 0.10 | 1.44 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 11/06/24 | -0.25 on 11/07/24 | -0.35 on 11/12/24 | ||
| Latest Earnings Date | 11/04/24 | 11/08/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||